Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
group decreased » groups decreased (Expand Search)
role decrease » fold decrease (Expand Search), rate decreased (Expand Search), road decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
group decreased » groups decreased (Expand Search)
role decrease » fold decrease (Expand Search), rate decreased (Expand Search), road decreased (Expand Search)
-
1801
-
1802
-
1803
-
1804
Summary of five key points guiding the Safe Steps evaluation and implementation.
Published 2025Subjects: -
1805
Study Data.
Published 2025“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
-
1806
Study outcomes.
Published 2025“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
-
1807
Patient characteristics.
Published 2025“…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
-
1808
Comparison of eye drop instillation success rates across different age groups.
Published 2025Subjects: -
1809
-
1810
Determinants of Parapapillary Choroidal Microvasculature in Glaucoma and Myopia.
Published 2025Subjects: -
1811
-
1812
-
1813
-
1814
-
1815
-
1816
-
1817
-
1818
-
1819
-
1820